Mateon Therapeutics Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | 0.07 0.1 | Capitalization | 15.27M 20.88M |
---|---|---|---|---|---|
Net income 2022 | 5M 6.84M | Net income 2023 | -7M -9.57M | EV / Sales 2022 | - |
Net Debt 2022 | 11.02M 15.06M | Net Debt 2023 | 12.4M 16.96M | EV / Sales 2023 | 395,316,686 x |
P/E ratio 2022 |
4.5
x | P/E ratio 2023 |
-1.91
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.03% |
Managers | Title | Age | Since |
---|---|---|---|
Vuong Trieu
CEO | Chief Executive Officer | 59 | 19-04-21 |
Director of Finance/CFO | 57 | 19-06-30 | |
Seymour H. Fein
CTO | Chief Tech/Sci/R&D Officer | 75 | 20-01-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven King
BRD | Director/Board Member | 59 | 20-05-10 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-05-10 |
Vuong Trieu
CEO | Chief Executive Officer | 59 | 19-04-21 |
1st Jan change | Capi. | |
---|---|---|
+5.22% | 109B | |
+11.13% | 105B | |
-0.38% | 22.25B | |
-12.01% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.17% | 16.85B | |
+3.10% | 13.76B | |
+36.12% | 12.46B |